Investors in Ar

Pembroke VCT is a venture capital trust specializing in growth-stage companies across the health and fitness, apparel, media, and technology sectors. With a strategic focus on investing in high-potential ventures, Pembroke VCT supports companies poised for expansion and innovation. They provide not only financial investment but also strategic guidance and operational support to accelerate growth and achieve market leadership. Pembroke VCT's commitment to these sectors reflects their belief in the transformative impact of innovation and their dedication to fostering sustainable success in dynamic markets.

SPWOne, we were established by British entrepreneur and businessman Sir Peter Wood to invest in and support a range of innovative businesses across their lifecycle. Led by Sir Peter Wood and our experienced team, we have a global reach and a track record of substantial value creation. We are committed to partnering with ambitious entrepreneurs and driving growth through strategic investments and operational support.

Amadeus Capital Partners, we are a global technology investor headquartered in London, UK, with an office in Cambridge, UK. Since our founding in 1997, we have specialized in investing in high-growth technology companies across sectors such as Artificial Intelligence, Digital Health, Cybersecurity, Enterprise Software, and FinTech. Our track record demonstrates our commitment to backing ambitious entrepreneurs and supporting them in scaling their businesses internationally. We provide early-stage to growth-stage funding, partnering with founders from inception through to exit. Known for our deep sector expertise and global network, we take a hands-on approach to building successful and sustainable companies.

MVM Life Science Partners, we are a specialized healthcare investment firm focused on early-stage and growth-stage companies in the life sciences sector. Founded in 1997 and headquartered in London, our firm invests globally in innovative biopharmaceuticals, medical technology, diagnostics, and digital health companies. Our approach combines deep sector expertise with strategic support to help our portfolio companies achieve their full potential. We have a strong track record of supporting groundbreaking therapies and technologies that make a significant impact on healthcare outcomes worldwide.

Winton Capital Management, we are a pioneering quantitative investment management firm founded in 1997 by Sir David Harding. Our approach is rooted in original research, rigorous statistical analysis, and deep market expertise, allowing us to develop and implement innovative investment strategies. We cater to a distinguished client base, including some of the world’s largest institutional investors, delivering customized solutions aimed at achieving consistent performance across diverse market conditions. Headquartered in London, our global presence enables us to manage substantial assets while continually advancing our quantitative finance capabilities.

Proxy Ventures is dedicated to helping startups succeed by providing strategic investments and amplifying their brand presence. As an investor, Proxy Ventures partners with early-stage companies to fuel their growth and development. Beyond financial backing, Proxy Ventures offers valuable expertise and support to accelerate the trajectory of startups, aiming to build strong, impactful brands that resonate in their respective markets.

Distill Ventures specializes in providing investment and strategic support to spirits entrepreneurs aiming to create global drinks brands. The firm collaborates closely with founders to accelerate the growth of their businesses through capital infusion, industry expertise, and operational guidance. Distill Ventures' approach is tailored to nurturing innovation in the spirits industry, fostering creativity and market expansion for emerging brands. With a global perspective and deep sector knowledge, Distill Ventures aims to partner with ambitious entrepreneurs to build the next generation of iconic drinks brands. For more details on their investment criteria and portfolio, please visit the Distill Ventures website.

Founded in 1996, Albion Capital Group LLP is a leading venture capital trust (VCT) manager dedicated to identifying and supporting ambitious, growing businesses. At Albion Capital, we manage a diverse portfolio of VCTs and institutional funds, providing crucial support and investment to high-potential enterprises across various sectors. We specialize in backing innovative businesses at different stages of growth, offering strategic guidance and financial backing to fuel their development. Our commitment is to foster entrepreneurial success and create value for our investors through a disciplined investment approach and deep market expertise. With a robust track record spanning decades, we at Albion Capital Group continue to play a pivotal role in the UK's venture capital landscape, driving growth and innovation in partnership with dynamic entrepreneurs and management teams.

Episode1 Ventures is a venture capital fund dedicated to investing in early-stage technology companies primarily based in London, UK. The firm focuses on supporting innovative startups with disruptive potential across various sectors. Episode1 Ventures provides crucial funding and strategic guidance to help startups scale their operations and achieve market traction. With a proactive investment approach, the firm aims to identify promising opportunities and partner with visionary entrepreneurs to drive long-term growth and success.

Arts Alliance Ventures, we are a venture capital organization dedicated to promoting entrepreneurship across Europe. We advise on investments on behalf of the Høegh family, specializing in technology-enabled service companies. Our focus includes sectors such as film, online marketing, and advertising, with a keen interest in companies serving both consumer and business markets. Since 1996, we have taken a proactive approach to investing, collaborating closely with entrepreneurs and management teams to foster the growth of outstanding companies. We have advised on investments in over 60 companies and have also internally incubated several ventures within Arts Alliance Ventures.

UCL Business (UCLB), we are at the forefront of technology transfer and commercialization, serving as the commercialization arm of University College London (UCL). Our mission is to maximize the impact of UCL's research by transforming innovative discoveries into real-world applications and products. We specialize in facilitating partnerships with industry, licensing technologies, and supporting the formation of spin-out companies. We play a pivotal role in bridging academia and industry, providing strategic advice, intellectual property management, and business development support to researchers and entrepreneurs. Our dedicated team is committed to driving innovation and economic growth through effective technology commercialization.

Kyotherm is a leading European Energy-as-a-Service investment firm and energy producer focused on renewable heating and energy efficiency projects. We specialize in diverse technologies such as solar thermal, biomass, geothermal, energy storage, waste heat recovery, and district heating networks. Collaborating closely with energy service companies and project developers, Kyotherm offers comprehensive turnkey solutions encompassing design-build, operation-maintenance, and financing. Our goal is to drive decarbonization efforts by reducing energy consumption and promoting sustainable practices across our projects.